Physician profile
Megan Gresh
NPI 1013178474
$3,368.36
in general payments reported to CMS, 2019-2025
9 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $13.82 · 2021: $88.26 · 2022: $93.52 · 2023: $2,421 · 2024: $57.41 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,250 · Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,250.00 |
| Food and Beverage | $363.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,489.80 | 2019-2023 | |
| Stryker Corporation | $634.54 | 2019-2025 | Tritanium, Stryker Nav3i, Es2 Spinal System |
| Cerapedics INC. | $98.13 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $51.50 | 2022 | |
| Medtronic, INC. | $27.78 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.97 | 2024 | |
| Biomarin Pharmaceutical INC. | $14.24 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.82 | 2020 | |
| Next Science LLC | $12.58 | 2023 | Xperience, Surgx, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Gresh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.